Login

Getting Ahead of What Comes Next |Natalie Sandman,General Partner,Spark Capital 00:10:00

Share On Facebook Share On Twitter

Natalie Sandman is the General Partner, Early at Spark Capital.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Evolution of ETFs: A Journey Through the Years
00:10:00
Banyan Gold CEO Tara Christie Discusses Yukon Projects and Market Outlook at 1-2-1 Mining Conference in New York
00:10:00
RAM interview - Nordic Summit 2019 | Andrew Fraser, CEO, RAM Active Investments SAAS OF 30 JUN 2023
00:10:00
Academy Securities: Empowering Veterans with Industry Expertise
00:10:00
Overview of AIM ImmunoTech's Pancreatic Cancer Program with Promising Follow-On Data Release| Thomas Equels, CEO, AIM ImmunoTech Inc.
00:10:00
Drake Dettore Shares Insights on Landing an Investment Banking Role at Bryant Park Capital|Drake Dettore, Investment Banking Analyst,Bryant Park Capital
00:10:00
Do I Need to Pay Taxes on My Social Security Payments?" | Jake, Financial Advisor, Savant Wealth Management
00:10:00
ISC CEO Discusses Company Strategy and Outlook | Shawn B. Peters - President and Chief Executive Officer of Information Services Corporation
00:10:00
Patents in a Pandemic: Leveraging IP for COVID-19 Innovation | Wade Ackerman - Partner of Covington & Burling
00:10:00
Balancing Act: Navigating Market Neutrality Amid High Valuations | Sébastien Page, CIO , T. Rowe Price.
00:10:00
Ward Brown Discusses Local Currency Debt and Opportunities in Emerging Markets
00:10:00
David Bramhill on Union Jack Oil's Portfolio and Current Projects | David Bramhill, Executive Chairman, Union Jack Oil Plc.

© 2017 - Neuhu+